Symposium Presentation 16.3
Preferential Effects of Metadoxine Extended-Release on Inattentive Subtype ADHD
Thursday, October 24, 2013 8:30 AM
Iris Manor, MD, ADHD unit, Geha Mental Health Center, Petach Tikva, Israel
Yaron Daniely, PhD, Alcobra Ltd., Tel Aviv
Jeffrey H. Newcorn, M.D., Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY
Stephen V. Faraone, PhD, State University of New York Upstate Medical University, Syracuse, NY
Joseph Biederman, MD, Massachusetts General Hospital, Boston, MA
Lenard Adler, MD, New York University School of Medicine, New York, NY
